Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jul;203(1):47.e1-5.
doi: 10.1016/j.ajog.2010.02.038. Epub 2010 May 15.

Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles

Anthony Shanks  1 , Gilad Gross, Tammy Shim, Jenifer Allsworth, Yoel Sadovsky, Ibrahim Bildirici
Affiliations
Randomized Controlled Trial

Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles

Anthony Shanks et al. Am J Obstet Gynecol. 2010 Jul.

Abstract

Objective: To estimate the effect of antenatal glucocorticoid administration on fetal lung maturity in pregnancies with known fetal lung immaturity between the 34th and 37th weeks of gestation.

Study design: Pregnancies between 34(0/7) and 36(6/7) weeks undergoing amniocentesis to determine fetal lung maturity were targeted. Women with negative results (TDx-FLM-II <45 mg/g) were randomly assigned to intramuscular glucocorticoid injection or no treatment. A repeat TDx-FLM-II test was obtained 1 week after enrollment.

Results: Thirty-two women who met inclusion criteria were randomly assigned. Seven women delivered within a week of testing for fetal lung maturity, and were excluded from the analysis. Ten received glucocorticoid and 15 did not. Women assigned to glucocorticoids had a mean increase TDx-FLM-II in 1 week of 28.37 mg/g. Women assigned to no-treatment had an increase of 9.76 mg/g (P < .002).

Conclusion: A single course of intramuscular glucocorticoids after 34 weeks in pregnancies with documented fetal lung immaturity significantly increases TDx- FLM-II.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Randomization, treatment and follow-up of patients.
Figure 2
Figure 2. Mean TDx-FLM-II increase in one week
See this image and copyright information in PMC

References

    1. Martin JA, Kung HC, Mathews TJ, Hoyert DL, Strobino DM, Guyer B, et al. Annual summary of vital statistics: 2006. Pediatrics. 2008 Apr;121(4):788–801. - PubMed
    1. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database of systematic reviews. 2006;3:CD004454. Online. - PubMed
    1. ACOG Committee Opinion No. 402. Antenatal corticosteroid therapy for fetal maturation. Obstetrics and gynecology. 2008 Mar;111(3):805–7. - PubMed
    1. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. American journal of obstetrics and gynecology. 1995 Jul;173(1):322–35. - PubMed
    1. Robertson PA, Sniderman SH, Laros RK, Jr, Cowan R, Heilbron D, Goldenberg RL, et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. American journal of obstetrics and gynecology. 1992 Jun;166(6 Pt 1):1629–41. discussion 41-5. - PubMed

Publication types